MicroRNAs in benign and malignant hematopoiesis

Sharathkumar Bhagavathi, Magdalena Czader

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are a family of 19- 24- nucleotide noncoding RNAs that regulate messenger RNA function at the posttranscriptional and translational level. Recent literature demonstrates a significant role of miRNAs in normal and malignant hematopoiesis. Specific miRNAs have been shown to regulate each step of hematopoiesis starting at the level of multipotent progenitors through terminal stages of myeloid and lymphoid differentiation. Similarly, individual miRNAs and miRNA signatures have been associated with specific hematologic malignancies. There is accumulating evidence that miRNAs can be used for diagnostic, prognostic, and therapeutic purposes. This review highlights the current status of knowledge on miRNA in normal and malignant hemato- poiesis.

Original languageEnglish
Pages (from-to)1276-1281
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume134
Issue number9
StatePublished - Sep 2010

Fingerprint

Hematopoiesis
MicroRNAs
Untranslated RNA
Hematologic Neoplasms
Nucleotides
Messenger RNA

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

MicroRNAs in benign and malignant hematopoiesis. / Bhagavathi, Sharathkumar; Czader, Magdalena.

In: Archives of Pathology and Laboratory Medicine, Vol. 134, No. 9, 09.2010, p. 1276-1281.

Research output: Contribution to journalArticle

@article{b6e14f02d86d48c196116089610bdbe6,
title = "MicroRNAs in benign and malignant hematopoiesis",
abstract = "MicroRNAs (miRNAs) are a family of 19- 24- nucleotide noncoding RNAs that regulate messenger RNA function at the posttranscriptional and translational level. Recent literature demonstrates a significant role of miRNAs in normal and malignant hematopoiesis. Specific miRNAs have been shown to regulate each step of hematopoiesis starting at the level of multipotent progenitors through terminal stages of myeloid and lymphoid differentiation. Similarly, individual miRNAs and miRNA signatures have been associated with specific hematologic malignancies. There is accumulating evidence that miRNAs can be used for diagnostic, prognostic, and therapeutic purposes. This review highlights the current status of knowledge on miRNA in normal and malignant hemato- poiesis.",
author = "Sharathkumar Bhagavathi and Magdalena Czader",
year = "2010",
month = "9",
language = "English",
volume = "134",
pages = "1276--1281",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "9",

}

TY - JOUR

T1 - MicroRNAs in benign and malignant hematopoiesis

AU - Bhagavathi, Sharathkumar

AU - Czader, Magdalena

PY - 2010/9

Y1 - 2010/9

N2 - MicroRNAs (miRNAs) are a family of 19- 24- nucleotide noncoding RNAs that regulate messenger RNA function at the posttranscriptional and translational level. Recent literature demonstrates a significant role of miRNAs in normal and malignant hematopoiesis. Specific miRNAs have been shown to regulate each step of hematopoiesis starting at the level of multipotent progenitors through terminal stages of myeloid and lymphoid differentiation. Similarly, individual miRNAs and miRNA signatures have been associated with specific hematologic malignancies. There is accumulating evidence that miRNAs can be used for diagnostic, prognostic, and therapeutic purposes. This review highlights the current status of knowledge on miRNA in normal and malignant hemato- poiesis.

AB - MicroRNAs (miRNAs) are a family of 19- 24- nucleotide noncoding RNAs that regulate messenger RNA function at the posttranscriptional and translational level. Recent literature demonstrates a significant role of miRNAs in normal and malignant hematopoiesis. Specific miRNAs have been shown to regulate each step of hematopoiesis starting at the level of multipotent progenitors through terminal stages of myeloid and lymphoid differentiation. Similarly, individual miRNAs and miRNA signatures have been associated with specific hematologic malignancies. There is accumulating evidence that miRNAs can be used for diagnostic, prognostic, and therapeutic purposes. This review highlights the current status of knowledge on miRNA in normal and malignant hemato- poiesis.

UR - http://www.scopus.com/inward/record.url?scp=77956453776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956453776&partnerID=8YFLogxK

M3 - Article

C2 - 20807046

AN - SCOPUS:77956453776

VL - 134

SP - 1276

EP - 1281

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 9

ER -